Augmentin-induced thrombocytosis: A maiden case series

Abstract

When an infected patient suffers from thrombocytosis, it is very difficult to identify beta-lactam antibiotic-induced cases of the disease and separate those from the possibility that thrombocytosis is an acute-phase reaction in the infected patient. We present 3 cases who were treated with Augmentin for various indications and developed thrombocytosis during the treatment course. The Naranjo probability scale indicates Augmentin as the possible cause of the thrombocytosis in all our patients.